CUBOSOME

作品数：2被引量：4H指数：1
导出分析报告
相关期刊：《Nano Research》更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-2
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
CD44 and CD221 directed magnetic cubosomes for the targeted delivery of helenalin to rhabdomyosarcoma cells
《Nano Research》2023年第2期2915-2926,共12页Hakmin Mun Yuriy Chaban Tanveer A.Tabish Nanasaheb Thorat Nathan Cowieson CDavid Owen Helen E.Townley 
supported by the Pyongyang University of Science and Technology(PUST)-UK scholarship,the Williams Fund(Oxford Hospitals Charity,No.0085);the UK national electron bio-imaging centre(No.NT32452);the Marie Sklodowska–Curie Grant Agreement(No.840964).
Confining chemotherapy to tumour sites by means of active targeting nanoparticles(NPs)may increase the treatment effectuality while reducing potential side effects.Cubosomes are one of the next-generation drug deliver...
关键词：CUBOSOME active targeting RHABDOMYOSARCOMA helenalin nanoparticle functionalization 
Cubosome nanoparticles for enhanced delivery of mitochondria anticancer drug elesclomol and therapeutic monitoring via sub-cellular NAD(P) H multi-photon fluorescence lifetime imaging被引量：4
《Nano Research》2019年第5期991-998,共8页Ana R.Faria Oscar F.Silvestre Christian Maibohm Ricardo M.R.Adao Bruno F.B.Silva Jana B.Nieder 
Elesclomol (ELC) is an anticancer drug inducing mitochondria cytotoxicity through reactive oxygen species.Here,for the first time,we encapsulate the poorly water soluble ELC in monoolein-based cubosomes stabilized wit...
关键词：CUBOSOMES mitoch on dria reactive oxyge n species elesclomol NAD(P)H fluoresce NEE lifetime anticancer therapy 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部